Evidence ‘consistent with causality’ but vaccination programme must continue, says drug safety specialist
Drug safety experts in the UK believe there could be a causal link between the Oxford/AstraZeneca Covid jab and very rare blood clots but say vaccination programmes must continue, with risk mitigation for women under 55.
Prof Saad Shakir, the director of the drug safety research unit (DSRU) at Southampton University, said the evidence accumulated in Europe and the UK “is consistent with causality”.
